A possible new Covid-19 vaccine could be accessible for more of the world
The protein subunit vaccine, which can be manufactured using engineered yeast, has shown promise in preclinical studies.
The protein subunit vaccine, which can be manufactured using engineered yeast, has shown promise in preclinical studies.
Novel lysin Abp013 has shown promising antimicrobial ability against Acinetobacter baumannii and Klebsiella pneumoniae.
Online MICRO internship program brings remote opportunities to undergrads.
MIT Sandbox inspires highly sought health care innovations with its new Independent Activities Period program.
Ruehr's new work, "Requiem," honors both personal and global losses.
The annual event aims to realize the promise of "new normal" education through community and technology.
Cecilia Stuopis, Peko Hosoi, and Ian Waitz describe a shift in policy that aims for a gradual return to normalcy.
A computational study shows that dozens of mutations help the virus’ spike protein evade antibodies that target SARS-CoV-2.
MIT experiment finds people will respond to cues from neighbors about activities and risk preferences.
Collective intelligence methodology identifies key findings to accelerate the pace of innovation and build health resilience.
Tiny Tides is an automated fast-flow instrument that can synthesize peptide-nucleic acids in a single shot.
In 2.C01, George Barbastathis demonstrates how mechanical engineers can use their knowledge of physical systems to keep algorithms in check and develop more accurate predictions.
MIT community members made headlines around the world for their innovative approaches to addressing problems local and global.
Top Institute stories dealt with the return to campus and continued response to Covid-19, MIT’s commitments to climate action, its support of a diverse community, and more.
The year’s popular research stories include a promising new approach to cancer immunotherapy, the confirmation of a 50-year-old theorem, and a major fusion breakthrough.